Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
出版年份 2022 全文链接
标题
Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2022-06-02
DOI
10.1200/jco.21.02745
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort
- (2021) Willem J. Koemans et al. Gastric Cancer
- Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma
- (2021) Ruiping Wang et al. NATURE MEDICINE
- Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram
- (2021) Dexin Chen et al. Nature Communications
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer
- (2021) In-Seob Lee et al. CLINICAL CANCER RESEARCH
- REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer
- (2021) Katrin M. Sjoquist et al. GYNECOLOGIC ONCOLOGY
- Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study
- (2021) Sofie De Vuysere et al. BMC MEDICAL IMAGING
- Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency
- (2021) Xiaochuan Dong et al. GUT
- Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature
- (2021) Chuang Zhang et al. Frontiers in Immunology
- 1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
- (2021) B. Rau et al. ANNALS OF ONCOLOGY
- Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
- (2021) Andrew Chow et al. CANCER CELL
- Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07
- (2021) Yoshihiro Kakeji et al. Gastric Cancer
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients
- (2021) Atsushi Sugimoto et al. PLoS One
- Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer
- (2021) Jing Guo et al. Nature Communications
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- (2021) Vikrant Kumar et al. Cancer Discovery
- 18F-Fludeoxyglucose–Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer
- (2021) Emma C. Gertsen et al. JAMA Surgery
- Primary and metastatic peritoneal surface malignancies
- (2021) Delia Cortés-Guiral et al. Nature Reviews Disease Primers
- Japanese gastric cancer treatment guidelines 2018 (5th edition)
- (2020) Gastric Cancer
- Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma
- (2020) Casey J. Allen et al. World Journal of Surgical Oncology
- Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)
- (2020) T. Voron et al. Journal of Visceral Surgery
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases
- (2020) ANNALS OF SURGICAL ONCOLOGY
- Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence
- (2020) Sanae Kaji et al. Gastric Cancer
- Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine model
- (2020) Hon Lyn Tan et al. EJSO
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer
- (2020) Mohammad Alyami et al. EJSO
- Peritoneal Metastatic Cancer Stem Cells of Gastric Cancer with Partial Mesenchymal-Epithelial Transition and Enhanced Invasiveness in an Intraperitoneal Transplantation Model
- (2020) Xiao-Hai Song et al. Gastroenterology Research and Practice
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial
- (2020) Han Kwang Yang et al. Lancet Gastroenterology & Hepatology
- Mapping physical tumor microenvironment and drug delivery
- (2019) Hadi T. Nia et al. CLINICAL CANCER RESEARCH
- Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview
- (2019) Miguel Alberto et al. CLINICAL & EXPERIMENTAL METASTASIS
- Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
- (2019) D Dong et al. ANNALS OF ONCOLOGY
- The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
- (2019) Koki Nakanishi et al. Gastric Cancer
- Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
- (2019) Pierre-Emmanuel Bonnot et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
- (2019) Rui-hua Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer
- (2019) Su‐Jin Shin et al. ONCOLOGIST
- Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
- (2019) Ruiping Wang et al. GUT
- A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages
- (2019) Matthew B. Buechler et al. IMMUNITY
- Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
- (2019) Mohammad Alyami et al. LANCET ONCOLOGY
- Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
- (2019) Gandhi T. K. Boopathy et al. Frontiers in Cell and Developmental Biology
- Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial)
- (2019) K. Misawa et al. BRITISH JOURNAL OF SURGERY
- Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
- (2019) Shuichi Sakamoto et al. OncoImmunology
- Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases
- (2019) Olga Kersy et al. Frontiers in Oncology
- The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
- (2019) John Kwon et al. Cancer Discovery
- Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma
- (2018) Jun H. Lee et al. ANNALS OF SURGERY
- Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer
- (2018) Koichi Sawaki et al. ANNALS OF SURGICAL ONCOLOGY
- Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer
- (2018) M. Kanda et al. BRITISH JOURNAL OF SURGERY
- A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial
- (2018) Naoto Takahashi et al. Gastric Cancer
- Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
- (2018) Hironori Ishigami et al. JOURNAL OF CLINICAL ONCOLOGY
- CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
- (2018) Jennifer Pasquier et al. Molecular Cancer
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
- (2018) K Muro et al. ANNALS OF ONCOLOGY
- Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
- (2018) WonJae Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET ONCOLOGY
- The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer
- (2017) Jacopo Desiderio et al. EUROPEAN JOURNAL OF CANCER
- Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)
- (2017) Hitoshi Katai et al. Gastric Cancer
- Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells
- (2017) Takatsugu Ishimoto et al. GASTROENTEROLOGY
- Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma
- (2017) Dilsa Mizrak Kaya et al. JOURNAL OF SURGICAL ONCOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Tissue Force Programs Cell Fate and Tumor Aggression
- (2017) Jason J. Northey et al. Cancer Discovery
- Gastric peritoneal carcinomatosis - a retrospective review
- (2017) Hwee Leong Tan et al. World Journal of Gastrointestinal Oncology
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis
- (2016) R.F. Ramos et al. EJSO
- Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan
- (2016) Koji Kono et al. Gastric Cancer
- Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
- (2016) Daisuke Kobayashi et al. Gastric Cancer
- Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
- (2016) Hironori Ishigami et al. Gastric Cancer
- Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
- (2016) Dexter Yak Seng Chan et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma
- (2016) H Gurler Main et al. ONCOGENE
- Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination
- (2016) Junji Kurashige et al. Scientific Reports
- Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis
- (2016) Lucia Cottone et al. OncoImmunology
- Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin – a longitudinal experience from a prospectively collected database of 1108 patients
- (2015) Florian Seyfried et al. BMC CANCER
- Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases
- (2015) Hironori Shiozaki et al. JOURNAL OF SURGICAL ONCOLOGY
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Modern imaging techniques for preoperative detection of distant metastases in gastric cancer
- (2015) Robert M Kwee WORLD JOURNAL OF GASTROENTEROLOGY
- GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study
- (2014) Olivier Glehen et al. BMC CANCER
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis
- (2014) Gaya Spolverato et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots
- (2014) Liang Cao et al. Journal of Translational Medicine
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
- (2013) Joji Kitayama et al. ANNALS OF SURGICAL ONCOLOGY
- Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: Results of a multicentre retrospective study
- (2013) C. Honoré et al. EJSO
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
- (2013) Hideaki Shimada et al. Gastric Cancer
- Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy
- (2013) Ju-Hee Lee et al. Gastric Cancer
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients
- (2013) Zhen Li et al. TUMOR BIOLOGY
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
- (2011) Xiao-Jun Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic significance of peritoneal washing cytology in patients with gastric cancer
- (2011) S. D. Lee et al. BRITISH JOURNAL OF SURGERY
- The EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer
- (2011) K. Yasumoto et al. CLINICAL CANCER RESEARCH
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Analysis for the Combination Expression of CK20, FABP1 and MUC2 is Sensitive for the Prediction of Peritoneal Recurrence in Gastric Cancer
- (2011) Y. Satoh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Investigation of the recurrence patterns of gastric cancer following a curative resection
- (2011) Jingyu Deng et al. SURGERY TODAY
- Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
- (2010) Olivier Glehen et al. ANNALS OF SURGICAL ONCOLOGY
- Surgical treatment for peritoneal carcinomatosis from gastric cancer
- (2010) Y. Yonemura et al. EJSO
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
- (2010) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis
- (2010) Zhi-Dong Lv et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Predictive Factors Improving Survival After Gastrectomy in Gastric Cancer Patients with Peritoneal Carcinomatosis
- (2010) Masayoshi Hioki et al. WORLD JOURNAL OF SURGERY
- Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer
- (2010) Paul H Sugarbaker World Journal of Gastrointestinal Oncology
- Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil
- (2009) Marcello F. Fanelli et al. International Journal of Clinical Oncology
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Peritoneal Metastasis: Detection with 16– or 64–Detector Row CT in Patients Undergoing Surgery for Gastric Cancer
- (2009) Su Jin Kim et al. RADIOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Locoregional treatment of peritoneal carcinomatosis from gastric cancer
- (2008) F. Bozzetti et al. JOURNAL OF SURGICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
- (2008) Mitsuru Sasako et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started